Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Co-Diagnostics, Inc logo — the Power to Know

Co-Diagnostics, Inc

the Power to Know

Founded 2013 United States Salt Lake City, United States 88 employees IPO Total: $11.80M Biotechnology

General Information

Company Name Co-Diagnostics, Inc
Founded Year 2013
Location United States Salt Lake City, United States +1
Employees 88
Industries Biotechnology
Funding Stage IPO
Social

Get notified when Co-Diagnostics, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Co-Diagnostics, Inc

Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics and transform healthcare delivery on a global scale. The company's patented Co-Primers™ technology aims to innovate disease detection and life sciences research. Co-Dx is preparing to launch the Co-Dx PCR Pro™ instrument and tests, an at-home and point-of-care real-time PCR testing platform. This platform seeks to make high-quality real-time PCR diagnostics widely accessible, especially in remote areas, at the point-of-care, or at home, all at affordable prices. The company's slogan "the Power to Know" reflects its commitment to empowerment through access to accurate and affordable diagnostic technology. With a focus on bringing robust, high-quality, and affordable PCR technology to regions with the greatest need, Co-Diagnostics, Inc aims to have a positive impact on global healthcare. Co-Diagnostics, Inc is positioned to disrupt the molecular diagnostics industry and expand the availability of gold-standard infectious disease testing. However, the lack of specific information regarding industries, headquarters, and past investments leaves room for further evaluation of the company's growth and potential investors and partnerships.

Taxonomy: Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, Primer Design, Infectious Disease, NGS, POCT, Healthcare Innovation, Point-of-Care Testing, At-Home Testing, Global Impact

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Equity •••••• - 01 May 2026
Post Ipo Equity •••••• - 01 Sep 2025
Grant •••••• 1
Investor
01 Jul 2023
Post Ipo Equity •••••• - 01 Jan 2020
IPO •••••• - 01 Jul 2017

Co-Diagnostics, Inc Alternatives & Competitors

Co-Diagnostics, Inc vs
Senzo Health
Senzo Health United States

PCR-Accurate Lateral Flow Testing

Undisclosed
8 employees
Biotechnology, Health Care
Compare Co-Diagnostics, Inc vs Senzo Health
Co-Diagnostics, Inc vs
Diaxxo AG
Diaxxo AG Switzerland

PCR Diagnostics Within Minutes

11 employees
Health Care, IT
Co-Diagnostics, Inc vs
Molbio Diagnostics
Molbio Diagnostics India

Molbio is a disruptor in the global healthcare landscape, shifting existing paradigms in point-of-ca...

Series Unknown
588 employees
Biotechnology, Health Care
Compare Co-Diagnostics, Inc vs Molbio Diagnostics
Also compare with: Co-Diagnostics, Inc vs Biomeme, Inc. Biomeme, Inc.

FAQ About Co-Diagnostics, Inc

the Power to Know
Co-Diagnostics, Inc was founded in 2013.
Co-Diagnostics, Inc is headquartered in Salt Lake City, United States.
Co-Diagnostics, Inc operates in the following industries: Biotechnology.
Co-Diagnostics, Inc has approximately 88 employees.
Co-Diagnostics, Inc has completed 5 funding rounds, raising a total of $11.80M. The latest funding stage is IPO.
Top alternatives and competitors to Co-Diagnostics, Inc include Senzo Health, Diaxxo AG, Molbio Diagnostics, Biomeme, Inc., Labsystems Diagnostics Oy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Co-Diagnostics, Inc and Senzo Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Co-Diagnostics, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy